Perrigo R And D Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PERRIGO R AND D, and what generic and branded alternatives to PERRIGO R AND D drugs are available?
PERRIGO R AND D has forty-four approved drugs.
Drugs and US Patents for Perrigo R And D
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Perrigo R And D | IBUPROFEN | ibuprofen | TABLET;ORAL | 077349-001 | Jun 21, 2005 | OTC | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Perrigo R And D | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | dextromethorphan hydrobromide; guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 207602-002 | Mar 5, 2018 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Perrigo R And D | RANITIDINE HYDROCHLORIDE | ranitidine hydrochloride | TABLET;ORAL | 091429-001 | May 11, 2011 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.